Home
Guide
Picks
High Yield
Dates
Monthly
Screener
Resources
ESG
Retire
Channels
Continue to site >
Trending ETFs
Rating
Sector Rating
Recommendation *
Avoid
Neutral
Fair
Quality
Rating Breakdown
Avg.
Relative Strength
The relative strength of a dividend stock indicates whether the stock is uptrending or not. The major determining factor in this rating is whether the stock is trading close to its 52-week-high.
Overall Yield Attractiveness
If a stock’s yield is above or near the market average then it will be rated higher within this parameter. High dividend yields (usually over 10%) should be considered extremely risky, while low dividend yields (1% or less) are simply not very beneficial to long-term investors.
Dividend Reliability
A stock’s dividend reliability is determined by a healthy payout ratio that is higher than other stocks. A company that pays out close to half its earnings as dividends and retains the other half of earnings has ample room to grow its business and pay out more dividends in the future.
Dividend Uptrend
A stock’s Dividend Uptrend rating is dependent on the company’s price-to-earnings (P/E) ratio to evaluate whether or not a stock’s dividend is likely to trend upward. If a stock is valued near, or slightly below the market average, research has shown that the market expects the stock’s dividend to increase.
Earnings Growth
A stock’s Earnings Growth rating evaluates a company’s expected EPS for the current financial year and compares it to next financial year’s expected EPS. Stocks with single-digit growth estimates will have a higher rating than others, as our research has shown that well-established dividend-paying companies have modest earnings growth estimates.
Upgrade to Premium to get unlimited access to Ratings, Recommendations, Payout Estimates, and more.
You take care of your investments. We like that.
Upgrade to Premium to access your Watchlist and more.
Or Login to Your Premium Account

BlackRock Future Health ETF

Active ETF
BMED
Dividend policy
None
Price as of:
$26.98 -0.47 -1.71%
primary theme
Health Care Sector Equity
BMED (ETF)

BlackRock Future Health ETF

Dividend policy
None
Price as of:
$26.98 -0.47 -1.71%
primary theme
Health Care Sector Equity
BMED (ETF)

BlackRock Future Health ETF

Dividend policy
None
Price as of:
$26.98 -0.47 -1.71%
primary theme
Health Care Sector Equity

Name

Price

Aum/Mkt Cap

YIELD & DIV

Exp Ratio

Watchlist

BlackRock Future Health ETF

BMED | Active ETF

$26.98

$6.61 M

0.00%

0.85%

Vitals

YTD Return

-10.3%

1 yr return

-0.9%

3 Yr Avg Return

N/A

5 Yr Avg Return

N/A

Net Assets

$6.61 M

Holdings in Top 10

30.7%

52 WEEK LOW AND HIGH

$27.5
$26.98
$32.37

Expenses

OPERATING FEES

Expense Ratio 0.85%

SALES FEES

Front Load N/A

Deferred Load N/A

TRADING FEES

Turnover N/A

Redemption Fee N/A

Min Investment

Standard (Taxable)

N/A

IRA

N/A

Fund Classification

Fund Type

Exchange Traded Fund

Investment Style

Health

Name

Price

Aum/Mkt Cap

YIELD & DIV

Exp Ratio

Watchlist

BlackRock Future Health ETF

BMED | Active ETF

$26.98

$6.61 M

0.00%

0.85%

BMED - Profile

Distributions

  • YTD Total Return -10.3%
  • 3 Yr Annualized Total Return N/A
  • 5 Yr Annualized Total Return N/A
  • Capital Gain Distribution Frequency N/A
  • Net Income Ratio -0.64%
DIVIDENDS
  • Dividend Yield 0.0%
  • Dividend Distribution Frequency Annually

Fund Details

  • Legal Name
    BlackRock Future Health ETF
  • Fund Family Name
    BlackRock
  • Inception Date
    Sep 29, 2020
  • Shares Outstanding
    240000
  • Share Class
    N/A
  • Currency
    USD
  • Domiciled Country
    United States
  • Manager
    Xiang Liu

Fund Description

Under normal market conditions, the fund will invest at least 80% of its net assets plus any borrowings for investment purposes in equity securities of companies principally engaged in the health sciences group of industries. While the fund will invest primarily in companies providing products and services for human health, it may also invest in companies whose products or services relate to the growth or survival of animals and plants. The fund is non-diversified.

BMED - Performance

Return Ranking - Trailing

Period BMED Return Category Return Low Category Return High Rank in Category (%)
YTD -10.3% -81.1% 25.3% 86.92%
1 Yr -0.9% -28.4% 33.9% 84.42%
3 Yr N/A* 2.4% 31.2% N/A
5 Yr N/A* 3.8% 31.1% N/A
10 Yr N/A* 8.4% 21.8% N/A

* Annualized

Return Ranking - Calendar

Period BMED Return Category Return Low Category Return High Rank in Category (%)
2020 N/A -13.6% 178.2% N/A
2019 N/A 3.8% 63.8% N/A
2018 N/A -49.7% 21.5% N/A
2017 N/A -59.8% 54.4% N/A
2016 N/A -36.6% 11.6% N/A

Total Return Ranking - Trailing

Period BMED Return Category Return Low Category Return High Rank in Category (%)
YTD -10.3% -81.1% 25.3% 86.92%
1 Yr -0.9% -30.4% 31.1% 83.78%
3 Yr N/A* -15.9% 31.2% N/A
5 Yr N/A* -7.4% 31.1% N/A
10 Yr N/A* 8.4% 21.8% N/A

* Annualized

Total Return Ranking - Calendar

Period BMED Return Category Return Low Category Return High Rank in Category (%)
2020 N/A -13.6% 178.2% N/A
2019 N/A 3.8% 63.8% N/A
2018 N/A -25.3% 22.2% N/A
2017 N/A -10.8% 54.4% N/A
2016 N/A -36.6% 11.6% N/A

BMED - Holdings

Concentration Analysis

BMED Category Low Category High BMED % Rank
Net Assets 6.61 M 490 K 51.6 B 97.78%
Number of Holdings 141 3 474 14.17%
Net Assets in Top 10 2.19 M 2.18 K 21.1 B 86.25%
Weighting of Top 10 30.72% 11.8% 100.0% 86.67%

Top 10 Holdings

  1. Seattle Genetics Inc 3.76%
  2. Genmab A/S 3.54%
  3. Genmab A/S 3.54%
  4. Genmab A/S 3.54%
  5. Genmab A/S 3.54%
  6. Genmab A/S 3.54%
  7. Genmab A/S 3.54%
  8. Genmab A/S 3.54%
  9. Genmab A/S 3.54%
  10. Genmab A/S 3.54%

Asset Allocation

Weighting Return Low Return High BMED % Rank
Stocks 		93.11% 0.09% 101.13% 94.58%
Cash 		6.89% -0.40% 99.91% 4.17%
Preferred Stocks 		0.00% 0.00% 7.04% 90.42%
Other 		0.00% -23.02% 7.97% 87.50%
Convertible Bonds 		0.00% 0.00% 0.21% 91.25%
Bonds 		0.00% 0.00% 14.85% 90.42%

Stock Sector Breakdown

Weighting Return Low Return High BMED % Rank
Healthcare 		95.70% 61.59% 100.00% 87.92%
Basic Materials 		2.79% 0.00% 8.42% 6.67%
Financial Services 		1.51% 0.00% 1.85% 5.00%
Utilities 		0.00% 0.00% 1.47% 90.00%
Technology 		0.00% 0.00% 19.99% 90.42%
Real Estate 		0.00% 0.00% 5.81% 90.42%
Industrials 		0.00% 0.00% 9.31% 90.83%
Energy 		0.00% 0.00% 0.76% 90.00%
Communication Services 		0.00% 0.00% 7.14% 90.00%
Consumer Defense 		0.00% 0.00% 28.15% 91.67%
Consumer Cyclical 		0.00% 0.00% 17.48% 90.42%

Stock Geographic Breakdown

Weighting Return Low Return High BMED % Rank
US 		70.99% 0.09% 100.00% 90.00%
Non US 		22.12% 0.00% 42.77% 16.25%

BMED - Expenses

Operational Fees

BMED Fees (% of AUM) Category Return Low Category Return High Rank in Category (%)
Expense Ratio 0.85% 0.08% 2.91% 38.72%
Management Fee 0.85% 0.00% 1.25% 88.33%
12b-1 Fee N/A 0.00% 1.00% N/A
Administrative Fee N/A 0.03% 0.25% N/A

Sales Fees

BMED Fees (% of AUM) Category Return Low Category Return High Rank in Category (%)
Front Load N/A 0.00% 5.75% N/A
Deferred Load N/A 1.00% 5.00% N/A

Trading Fees

BMED Fees (% of AUM) Category Return Low Category Return High Rank in Category (%)
Max Redemption Fee N/A 1.00% 2.00% N/A

Related Fees

Turnover provides investors a proxy for the trading fees incurred by mutual fund managers who frequently adjust position allocations. Higher turnover means higher trading fees.

BMED Fees (% of AUM) Category Return Low Category Return High Rank in Category (%)
Turnover N/A 0.00% 256.00% N/A

BMED - Distributions

Dividend Yield Analysis

BMED Category Low Category High BMED % Rank
Dividend Yield 0.00% 0.00% 2.44% 91.21%

Dividend Distribution Analysis

BMED Category Low Category High Category Mod
Dividend Distribution Frequency Annually Annually Semi-Annually Semi-Annually

Net Income Ratio Analysis

BMED Category Low Category High BMED % Rank
Net Income Ratio -0.64% -2.54% 1.92% 83.43%

Capital Gain Distribution Analysis

BMED Category Low Category High Capital Mode
Capital Gain Distribution Frequency

Dividend Payout History

View More +

BMED - Fund Manager Analysis

Managers

Xiang Liu

Start Date

Tenure

Tenure Rank

Sep 29, 2020

1.17

1.2%

Erin Xie

Start Date

Tenure

Tenure Rank

Sep 29, 2020

1.17

1.2%

Ms. Xie is the managing director and Portfolio Manager of BlackRock Advisor since 2006. Before becoming part of BlackRock Advisors in 2005, she was with State Street Research & Management since 2001. Ms. Xie began her investment career as a pharmaceutical analyst for Sanford Bernstein in 1999.

Jeff Lee

Start Date

Tenure

Tenure Rank

Sep 29, 2020

1.17

1.2%

Tenure Analysis

Category Low Category High Category Average Category Mode
0.06 24.22 6.7 1.62

Advertisement

×

Wait! Rates are rising, is your portfolio ready?

×